French and Benelux stocks-Factors to watch on November 2
French and Benelux stocks-Factors to watch on November 2 Nov 2 (Reuters) - Here are some of the main factors that may affect French and Benelux stocks on Monday:
FORVIA FRVIA.PA
French car part maker Forvia on Monday confirmed its guidance for the full 2006 after its sales revenues in the third quarter rose 1% to €5.08 billion ($5.68 billion).
SANOFI SASY.PA
RBC raised its target price for French pharma giant Sanofi to €80 up from a prior €75.
Pan-European market data:
European Equities speed guide...................EUR/EQUITY
FTSE Eurotop 300 index...............................FTEU3
DJ STOXX index.......................................STOXX
Top 10 STOXX sectors............................PGL.STOXXS
Top 10 EUROSTOXX sectors.......................PGL.STOXXES
Top 10 Eurotop 300 sectors......................PGL.FTEU3S
Top 25 European pct gainers........................PG.PEUR
Top 25 European pct losers.........................PL.PEUR
Main stock markets:
Dow Jones................DJI Wall Street report ......N
Nikkei 225..............N225 Tokyo report.............T
FTSE 100................FTSE London report............L
Xetra DAX..............GDAXI Frankfurt items..........F
CAC-40..................FCHI Paris items.............PA
World Indices.....................................0#.INDEX
Reuters survey of world bourse outlook.........EQUITYPOLL1
European Asset Allocation........................EUR/ASSET
Reuters News at a glance:
Top News.............TOP/NEWS
Equities..............TOP/EQE
Main oil report...........O/R
Main currency report.....FRX/
($1 = 0.8948 euros)
(Reporting by Gdansk newsroom)
((Gdansk Newsroom: +48 58 769 66 00;Paris Equities: +33 1 49 49 54 52))
Recent news on Sanofi SA
See all newsEurope Research Roundup: Capgemini, Italgas, Saab
French and Benelux stocks-Factors to watch on November 2
Sanofi teases appetite for larger deals, lifts 2026 growth targets under new CEO Garijo (updated)
Sanofi rises after Q3 beat, outlook upgrade
Sanofi lifts expectations for 2026 sales growth, looks to M&A